Standard Biotools (LAB) Long-Term Deferred Tax (2024 - 2026)

Standard Biotools (LAB) has 3 years of Long-Term Deferred Tax data on file, last reported at $270000.0 in Q1 2026.

• On a quarterly basis, Long-Term Deferred Tax changed N/A year-over-year to $270000.0 in Q1 2026; TTM through Mar 2026 was $270000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $38.6 million, up 184.07% from the prior year.
• Long-Term Deferred Tax for Q1 2026 stood at $270000.0, down from $38.6 million in the prior quarter.
• Over the last five years, Long-Term Deferred Tax for LAB reached as high as $38.6 million in Q4 2025 and fell as low as $270000.0 in Q1 2026.
• Historically, Long-Term Deferred Tax has averaged $17.5 million across 3 years, with a median of $13.6 million in 2024.
• On a YoY basis, Long-Term Deferred Tax climbed as much as 184.07% in 2025 and fell as far as 184.07% in 2025.
• Year by year, Long-Term Deferred Tax stood at $13.6 million in 2024, then soared by 184.07% to $38.6 million in 2025, then slumped by 99.3% to $270000.0 in 2026.
• Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $270000.0 in Q1 2026, $38.6 million in Q4 2025, and $13.6 million in Q4 2024.